Johnson & Johnson is in pole position to bring a drug targeting GPRC5D to market as a new therapeutic approach to multiple myeloma ... cells and serum fee light chain biomarkers that indicate ...

Fresenius Medical Care offers strong credit, a solid pipeline, but weak margins and limited short-term upside curb enthusiasm ...

In addition, the company offers DARZALEX/DARZALEX FASPRO for multiple myeloma (MM) and light-chain Amyloidosis; RYBREVANT for NSCLC; TECVAYLI and TALVEY for R/R MM; Kesimpta for Relapsing multiple ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

It joins a number of other BCMA-directed therapies for multiple myeloma, including GSK's first-to-market antibody-drug conjugate Blenrep (belantamab mafodotin), Bristol-Myers Squibb/bluebird bio's ...

West Fargo. Proceeds from the free-will lunch, silent auction, and bake sale will support Neil who is being treated for smoldering multiple myeloma. Neil has not been able to work since his ...

Using sequencing instruments from multiple vendors, scientists from the University of Utah Health, the University of Washington, PacBio, and elsewhere have developed what they claim is the most ...

Each device purports to provide a multi-user (aka multi-angle) 3D experience without needing special headsets or glasses. The images weren't static, either: Using the computer or iPad hooked up to ...

Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...

VENTURA, Calif. – Ventura Police arrested a 33-year-old man on numerous offenses after being found tampering with a neighbor's vehicle on Thille Street at 6:45 a.m. Saturday. VPD officers ...

But when things go wrong—like store shelves sitting empty or critical goods arriving damaged—the mystery of what happened often comes down to one key issue: a blind spot in the supply chain.